Clinical Microbiology Newsletter
Volume 32, Issue 3 , Pages 17-23, 1 February 2010

Diagnostic Testing for Encephalitis, Part I

  • Julie E. Reznicek, D.O.

      Affiliations

    • Department of Medicine, Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, Tennessee
  • ,
  • Karen C. Bloch, M.D.

      Affiliations

    • Departments of Medicine and Preventive Medicine, Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, Tennessee

Abstract

Encephalitis is characterized by both its pleomorphic clinical presentation and its diagnostic challenges. Fever, headache, and alteration of consciousness are classically present; however, the diversity of neurological symptoms can make it difficult to distinguish encephalitis from other infectious and non-infectious central nervous system conditions. Identification of a specific pathogen has important therapeutic and prognostic implications for an individual patient and has broader public health significance in potentially identifying a need for prophylaxis of contacts or environmental control of arthropod vectors. Despite the availability of nucleic acid amplification-based tests, a specific pathogen is identified in less than 50% of cases. This two-part review will focus on issues in diagnostic testing, such as specimen selection and optimal use of serology and PCR techniques for pathogens causing encephalitis in North America. Part I introduces basic features of encephalitis, including the initial evaluation of patients with possible encephalitis, and then discusses aspects of diagnostic testing for encephalitis caused by specific agents, including herpes simplex virus, the non-simplex Herpesviridae, enteroviruses, and agents associated with tick-borne diseases, specifically, Rocky Mountain spotted fever and ehrlichiosis.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Editor's Note: Part II of this article will appear in the February 15, 2010 issue of CMN (Volume 32, Number 4).

PII: S0196-4399(10)00002-4

doi:10.1016/j.clinmicnews.2010.01.001

Clinical Microbiology Newsletter
Volume 32, Issue 3 , Pages 17-23, 1 February 2010